cash flow reconciliationreview2025-12-31
Operating, investing and financing flows differ from the reported change in cash by 212000000, beyond tolerance 60450000.00.
Revenue
$37.45B
Fiscal year ended 2025-12-31Operating income
$5.44B
Fiscal year ended 2025-12-31Free cash flow
$2.91B
Fiscal year ended 2025-12-31CRH PUBLIC LTD CO (CRH) reported revenue of $37.45B and net income of $3.75B for the fiscal year ended 2025-12-31. This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from CRH PUBLIC LTD CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Cement, Hydraulic.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $37.45B | $35.57B | $34.95B | $32.72B | $29.21B |
| Cost of revenue | $23.92B | $22.87B | $22.99B | $21.91B | $19.38B |
| Gross profit | $13.53B | $12.70B | $11.96B | $10.82B | $9.83B |
| Operating income | $5.44B | $4.92B | $4.19B | $3.81B | $3.33B |
| Net income | $3.75B | $3.49B | $3.18B | $3.86B | $2.63B |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 677.00M | shares 689.50M | shares 729.20M | shares 764.10M | shares 786.80M |
| Pretax income | $4.80B | $4.71B | $4.01B | $3.46B | $3.10B |
| Income tax expense | $1.04B | $1.08B | $925.00M | $762.00M | $650.00M |
| Diluted EPS | $5.51 | $5.02 | $4.33 | $5.11 | $3.32 |
| Selling, general & administrative | $8.28B | $7.85B | $7.49B | $7.06B | $6.54B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cash & equivalents | $4.10B | $3.72B | $6.34B | $5.94B | $5.78B |
| Total assets | $58.33B | $50.61B | $47.47B | $45.32B | Unavailable |
| Current assets | $15.25B | $14.08B | $16.88B | $14.83B | Unavailable |
| Total liabilities | $32.85B | $27.76B | $25.85B | $22.28B | Unavailable |
| Current liabilities | $8.75B | $10.30B | $10.01B | $8.04B | Unavailable |
| Total equity incl. NCI | $25.05B | $22.47B | $21.29B | $22.73B | $21.25B |
| Temporary (mezzanine) equity | $430.00M | $384.00M | $333.00M | $308.00M | $336.00M |
| Inventory | $5.25B | $4.76B | $4.29B | $4.19B | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $13.10B | $11.06B | $9.16B | $9.20B | $9.45B |
| Long-term debt | $16.48B | $10.97B | $9.78B | $8.14B | Unavailable |
| Accounts payable | $3.26B | $3.21B | $3.15B | $2.93B | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | $5.62B | $4.99B | $5.02B | $3.80B | $3.98B |
| Capital expenditures | $2.71B | $2.58B | $1.82B | $1.52B | $1.55B |
| Investing cash flow | -$6.04B | -$6.29B | -$2.39B | -$917.00M | -$2.51B |
| Financing cash flow | $596.00M | -$1.19B | -$2.38B | -$2.50B | -$3.11B |
| Net change in cash | $388.00M | -$2.63B | $454.00M | $153.00M | -$1.94B |
| Stock-based compensation | $143.00M | $125.00M | $123.00M | $101.00M | $110.00M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $1.18B | $1.48B | $3.07B | $1.18B | $896.00M |
| Depreciation & amortization | $2.16B | $1.80B | $1.63B | $1.58B | $1.55B |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free cash flow | $2.91B | $2.41B | $3.20B | $2.28B | $2.42B |
| Gross margin | 36.1% | 35.7% | 34.2% | 33.1% | 33.6% |
| Operating margin | 14.5% | 13.8% | 12.0% | 11.6% | 11.4% |
| FCF margin | 7.8% | 6.8% | 9.2% | 7.0% | 8.3% |
| SBC / revenue | 0.4% | 0.4% | 0.4% | 0.3% | 0.4% |
| Current ratio | 1.74x | 1.37x | 1.69x | 1.84x | Unavailable |
| Revenue YoY growth | 5.3% | 1.8% | 6.8% | 12.0% | Unavailable |
| Net margin | 10.0% | 9.8% | 9.1% | 11.8% | 9.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 7.2% | 7.2% | 5.2% | 4.7% | 5.3% |
| Long-term debt / equity | 0.66x | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 21.7% | 23.0% | 23.0% | 22.0% | 21.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CRH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-18View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-05View SEC filing
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2024-12-31
Operating, investing and financing flows differ from the reported change in cash by 143000000, beyond tolerance 62910000.00.
cash flow reconciliationreview2023-12-31
Operating, investing and financing flows differ from the reported change in cash by 208000000, beyond tolerance 50170000.00.
cash flow reconciliationreview2022-12-31
Operating, investing and financing flows differ from the reported change in cash by 231000000, beyond tolerance 38000000.00.
cash flow reconciliationreview2021-12-31
Operating, investing and financing flows differ from the reported change in cash by 297000000, beyond tolerance 39790000.00.